Literature DB >> 3129939

Financial risk, hospital cost, and complications and comorbidities in medical non-complications and comorbidity-stratified diagnosis-related groups.

E Muñoz1, F Rosner, R Friedman, H Sterman, J Goldstein, L Wise.   

Abstract

A number of methods are being studied to modify and improve the accuracy of the Medicare Diagnosis-Related Group (DRG) hospital classification system. This study analyzed resource consumption for 2,431 medical Medicare patients in the 53 non-complicating condition-stratified (i.e., non-complication and comorbidity) medical DRGs. Resource consumption per patient increased as the number of complications and comorbidities per patient per DRG increased, as measured by total hospital cost, hospital length of stay, the number of diagnoses and procedures per patient, the percent outliers, and mortality. Patients with more than four complications and comorbidities generated significant financial risk ($5,667 loss per patient) under DRG reimbursement. This study raises the question of the equity of DRG reimbursement for the medical non-complication and comorbidity-stratified DRGs. A method for DRG adjustment based on complications and comorbidities should be implemented by Congress to assure equitable payment for patients in these medical DRGs.

Entities:  

Mesh:

Year:  1988        PMID: 3129939     DOI: 10.1016/0002-9343(88)90074-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

1.  The association of the number of comorbidities and complications with length of stay, hospital mortality and LOS high outlier, based on administrative data.

Authors:  Kazuaki Kuwabara; Yuichi Imanaka; Shinya Matsuda; Kiyohide Fushimi; Hideki Hashimoto; Koichi B Ishikawa; Hiromasa Horiguchi; Kenshi Hayashida; Kenji Fujimori
Journal:  Environ Health Prev Med       Date:  2008-03-29       Impact factor: 3.674

Review 2.  Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF): an appraisal of its pharmacoeconomic status in neutropenia associated with chemotherapy and autologous bone marrow transplant.

Authors:  K L Goa; H M Bryson
Journal:  Pharmacoeconomics       Date:  1994-01       Impact factor: 4.981

3.  Comorbidity as a correlate of length of stay for hospitalized patients with acute chest pain.

Authors:  K Matsui; L Goldman; P A Johnson; K M Kuntz; E F Cook; T H Lee
Journal:  J Gen Intern Med       Date:  1996-05       Impact factor: 5.128

4.  Risk Factors for Readmission After Knee Arthroplasty Based on Predictive Models: A Systematic Review.

Authors:  Satish M Mahajan; Chantal Nguyen; Justin Bui; Enomwoyi Kunde; Bruce T Abbott; Amey S Mahajan
Journal:  Arthroplast Today       Date:  2020-06-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.